{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:23:59Z","timestamp":1761719039864},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10048-021-00646-5","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T12:02:51Z","timestamp":1620475371000},"page":"187-194","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genotype\u2013phenotype correlations of heterozygous HTRA1-related cerebral small vessel disease: case report and systematic review"],"prefix":"10.1007","volume":"22","author":[{"given":"Haohan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junkui","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiewen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengmin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"issue":"11","key":"646_CR1","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1161\/STROKEAHA.114.004236","volume":"45","author":"H Nozaki","year":"2014","unstructured":"Nozaki H, Nishizawa M, Onodera O (2014) Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 45(11):3447\u20133453. https:\/\/doi.org\/10.1161\/STROKEAHA.114.004236","journal-title":"Stroke"},{"issue":"2","key":"646_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.008","volume":"20","author":"T Fukutake","year":"2011","unstructured":"Fukutake T (2011) Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. J Stroke Cerebrovasc Dis 20(2):85\u201393. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2010.11.008","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"646_CR3","unstructured":"Onodera O, Nozaki H, Fukutake T\n (1993\u20132020) HTRA1 Disorder. In: Adam MP, Ardinger HH, Pagon RA et al, editors. GeneReviews\u00ae [Internet]. Seattle: University of Washington, Seattle"},{"issue":"Pt 8","key":"646_CR4","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1093\/brain\/awv155","volume":"138","author":"E Verdura","year":"2015","unstructured":"Verdura E, Herve D, Scharrer E, Amador Mdel M, Guyant-Marechal L, Philippi A, Corlobe A, Bergametti F, Gazal S, Prieto-Morin C, Beaufort N, Le Bail B, Viakhireva I, Dichgans M, Chabriat H, Haffner C, Tournier-Lasserve E (2015) Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. Brain 138(Pt 8):2347\u20132358. https:\/\/doi.org\/10.1093\/brain\/awv155","journal-title":"Brain"},{"issue":"7","key":"646_CR5","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1161\/STROKEAHA.118.021283","volume":"49","author":"YC Lee","year":"2018","unstructured":"Lee YC, Chung CP, Chao NC, Fuh JL, Chang FC, Soong BW, Liao YC (2018) Characterization of heterozygous HTRA1 mutations in Taiwanese patients with cerebral small vessel disease. Stroke 49(7):1593\u20131601. https:\/\/doi.org\/10.1161\/STROKEAHA.118.021283","journal-title":"Stroke"},{"issue":"7","key":"646_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1517\/14728222.2010.487867","volume":"14","author":"D Zurawa-Janicka","year":"2010","unstructured":"Zurawa-Janicka D, Skorko-Glonek J, Lipinska B (2010) HtrA proteins as targets in therapy of cancer and other diseases. Expert Opin Ther Targets 14(7):665\u2013679. https:\/\/doi.org\/10.1517\/14728222.2010.487867","journal-title":"Expert Opin Ther Targets"},{"issue":"2\u20133","key":"646_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s0014-5793(96)01229-x","volume":"398","author":"J Zumbrunn","year":"1996","unstructured":"Zumbrunn J, Trueb B (1996) Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett 398(2\u20133):187\u2013192. https:\/\/doi.org\/10.1016\/s0014-5793(96)01229-x","journal-title":"FEBS Lett"},{"key":"646_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3389\/fneur.2020.00545","volume":"11","author":"M Uemura","year":"2020","unstructured":"Uemura M, Nozaki H, Kato T, Koyama A, Sakai N, Ando S, Kanazawa M, Hishikawa N, Nishimoto Y, Polavarapu K, Nalini A, Hanazono A, Kuzume D, Shindo A, El-Ghanem M, Abe A, Sato A, Yoshida M, Ikeuchi T, Mizuta I, Mizuno T, Onodera O (2020) HTRA1-Related cerebral small vessel disease: a review of the literature. Front Neurol 11:545. https:\/\/doi.org\/10.3389\/fneur.2020.00545","journal-title":"Front Neurol"},{"issue":"2","key":"646_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.abb.2011.10.007","volume":"516","author":"N Singh","year":"2011","unstructured":"Singh N, Kuppili RR, Bose K (2011) The structural basis of mode of activation and functional diversity: a case study with HtrA family of serine proteases. Arch Biochem Biophys 516(2):85\u201396. https:\/\/doi.org\/10.1016\/j.abb.2011.10.007","journal-title":"Arch Biochem Biophys"},{"issue":"21","key":"646_CR10","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1212\/wnl.0000000000002694","volume":"86","author":"H Nozaki","year":"2016","unstructured":"Nozaki H, Kato T, Nihonmatsu M, Saito Y, Mizuta I, Noda T, Koike R, Miyazaki K, Kaito M, Ito S, Makino M, Koyama A, Shiga A, Uemura M, Sekine Y, Murakami A, Moritani S, Hara K, Yokoseki A, Kuwano R, Endo N, Momotsu T, Yoshida M, Nishizawa M, Mizuno T, Onodera O (2016) Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology 86(21):1964\u20131974. https:\/\/doi.org\/10.1212\/wnl.0000000000002694","journal-title":"Neurology"},{"key":"646_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.abb.2017.04.004","volume":"621","author":"D Zurawa-Janicka","year":"2017","unstructured":"Zurawa-Janicka D, Wenta T, Jarzab M, Skorko-Glonek J, Glaza P, Gieldon A, Ciarkowski J, Lipinska B (2017) Structural insights into the activation mechanisms of human HtrA serine proteases. Arch Biochem Biophys 621:6\u201323. https:\/\/doi.org\/10.1016\/j.abb.2017.04.004","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"646_CR12","doi-asserted-by":"publisher","first-page":"14804","DOI":"10.1038\/s41598-017-14208-z","volume":"7","author":"AC Cabrera","year":"2017","unstructured":"Cabrera AC, Melo E, Roth D, Topp A, Delobel F, Stucki C, Chen CY, Jakob P, Banfai B, Dunkley T, Schilling O, Huber S, Iacone R, Petrone P (2017) HtrA1 activation is driven by an allosteric mechanism of inter-monomer communication. Sci Rep 7(1):14804. https:\/\/doi.org\/10.1038\/s41598-017-14208-z","journal-title":"Sci Rep"},{"issue":"3","key":"646_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nsmb.2013","volume":"18","author":"L Truebestein","year":"2011","unstructured":"Truebestein L, Tennstaedt A, M\u00f6nig T, Krojer T, Canellas F, Kaiser M, Clausen T, Ehrmann M (2011) Substrate-induced remodeling of the active site regulates human HTRA1 activity. Nat Struct Mol Biol 18(3):386\u2013388. https:\/\/doi.org\/10.1038\/nsmb.2013","journal-title":"Nat Struct Mol Biol"},{"key":"646_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fneur.2019.00693","volume":"10","author":"M Uemura","year":"2019","unstructured":"Uemura M, Nozaki H, Koyama A, Sakai N, Ando S, Kanazawa M, Kato T, Onodera O (2019) HTRA1 mutations identified in symptomatic carriers have the property of interfering the trimer-dependent activation cascade. Front Neurol 10:693. https:\/\/doi.org\/10.3389\/fneur.2019.00693","journal-title":"Front Neurol"},{"issue":"5","key":"646_CR15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1212\/wnl.56.5.628","volume":"56","author":"M O'Sullivan","year":"2001","unstructured":"O\u2019Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS (2001) MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 56(5):628\u2013634. https:\/\/doi.org\/10.1212\/wnl.56.5.628","journal-title":"Neurology"},{"issue":"D1","key":"646_CR16","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47(D1):D886\u2013D894. https:\/\/doi.org\/10.1093\/nar\/gky1016","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"646_CR17","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1212\/NXG.0000000000000434","volume":"6","author":"G Xiromerisiou","year":"2020","unstructured":"Xiromerisiou G, Marogianni C, Dadouli K, Zompola C, Georgouli D, Provatas A, Theodorou A, Zervas P, Nikolaidou C, Stergiou S, Ntellas P, Sokratous M, Stathis P, Paraskevas GP, Bonakis A, Voumvourakis K, Hadjichristodoulou C, Hadjigeorgiou GM, Tsivgoulis G (2020) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy revisited: Genotype-phenotype correlations of all published cases. Neurol Genet 6(3):e434. https:\/\/doi.org\/10.1212\/NXG.0000000000000434","journal-title":"Neurol Genet"},{"issue":"5","key":"646_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013423. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"7","key":"646_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/humu.22798","volume":"36","author":"KJ Van der Velde","year":"2015","unstructured":"Van der Velde KJ, Kuiper J, Thompson BA, Plazzer J-P, van Valkenhoef G, de Haan M, Jongbloed JDH, Wijmenga C, de Koning TJ, Abbott KM, Sinke R, Spurdle AB, Macrae F, Genuardi M, Sijmons RH, Swertz MA (2015) Evaluation of CADD scores in curated mismatch repair gene variants yields a model for clinical validation and prioritization. Hum Mutat 36(7):712\u2013719. https:\/\/doi.org\/10.1002\/humu.22798","journal-title":"Hum Mutat"},{"issue":"4","key":"646_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/strokeaha.109.568402","volume":"41","author":"P Adib-Samii","year":"2010","unstructured":"Adib-Samii P, Brice G, Martin RJ, Markus HS (2010) Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke 41(4):630\u2013634. https:\/\/doi.org\/10.1161\/strokeaha.109.568402","journal-title":"Stroke"},{"issue":"8","key":"646_CR21","doi-asserted-by":"publisher","first-page":"e0182822","DOI":"10.1371\/journal.pone.0182822","volume":"12","author":"P Kraft","year":"2017","unstructured":"Kraft P, Schuhmann MK, Garz C, Jandke S, Urlaub D, Mencl S, Zernecke A, Heinze HJ, Carare RO, Kleinschnitz C, Schreiber S (2017) Hypercholesterolemia induced cerebral small vessel disease. PLoS ONE 12(8):e0182822. https:\/\/doi.org\/10.1371\/journal.pone.0182822","journal-title":"PLoS ONE"},{"issue":"Pt 9","key":"646_CR22","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/brain\/awh223","volume":"127","author":"S Singhal","year":"2004","unstructured":"Singhal S, Bevan S, Barrick T, Rich P, Markus HS (2004) The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 127(Pt 9):2031\u20132038. https:\/\/doi.org\/10.1093\/brain\/awh223","journal-title":"Brain"},{"issue":"2","key":"646_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5853\/jos.2017.02110","volume":"20","author":"F Han","year":"2018","unstructured":"Han F, Zhai FF, Wang Q, Zhou LX, Ni J, Yao M, Li ML, Zhang SY, Cui LY, Jin ZY, Zhu YC (2018) Prevalence and risk factors of cerebral small vessel disease in a Chinese population-based sample. J Stroke 20(2):239\u2013246. https:\/\/doi.org\/10.5853\/jos.2017.02110","journal-title":"J Stroke"},{"issue":"3","key":"646_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10072-017-3231-z","volume":"39","author":"WY Zhang","year":"2018","unstructured":"Zhang WY, Xie F, Lu PL (2018) Two novel heterozygous HTRA1 mutations in two pedigrees with cerebral small vessel disease families. Neurol Sci 39(3):497\u2013501. https:\/\/doi.org\/10.1007\/s10072-017-3231-z","journal-title":"Neurol Sci"},{"issue":"12","key":"646_CR25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/cns.13047","volume":"24","author":"A Bougea","year":"2018","unstructured":"Bougea A (2018) Do heterozygous HTRA1 mutations carriers form a distinct clinical entity? CNS Neurosci Ther 24(12):1299\u20131300. https:\/\/doi.org\/10.1111\/cns.13047","journal-title":"CNS Neurosci Ther"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-021-00646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-021-00646-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-021-00646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T09:06:21Z","timestamp":1624957581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-021-00646-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1007\/s10048-021-00646-5","relation":{},"ISSN":["1364-6745","1364-6753"],"issn-type":[{"value":"1364-6745","type":"print"},{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"24 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the People's Hospital of Zhengzhou University, and written consent was obtained from all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}